苏丹与瑞典系统性红斑狼疮患者的免疫学与临床特征比较
该研究比较了苏丹(n=115)与瑞典(n=340)连续系统性红斑狼疮(SLE)患者的免疫学与临床特征,所有患者均符合1982年ACR分类标准,并以两国年龄性别匹配的健康对照建立检测 cut-off。结果显示苏丹患者抗Sm抗体更常见,而瑞典患者抗dsDNA抗体、抗组蛋白抗体及C1q结合免疫复合物更高;苏丹患者损伤评分更高,主要归因于颅/周围神经病变和糖尿病。
要点
- 苏丹SLE患者抗Sm抗体更常见,瑞典患者抗dsDNA、抗组蛋白抗体及CICs更高。
- 苏丹患者损伤评分更高,主要归因于颅/周围神经病变和糖尿病。
- 苏丹患者更年轻、病程更短,可能提示更严重病程并影响生存率。
核心结论
- 苏丹患者抗Sm抗体更常见而抗dsDNA抗体低于瑞典患者,且损伤评分更高,主要因神经病变和糖尿病。
- 苏丹患者更年轻且病程更短,可能提示更严重疾病进程并影响生存率。
研究设计与样本
- 纳入苏丹连续SLE患者115例和瑞典连续SLE患者340例,以及106例苏丹和318例瑞典年龄性别匹配对照。
- 所有患者均符合1982年ACR分类标准,检测10种ANA相关特异性抗体和C1q结合免疫复合物(CICs),cut-off基于两国对照分别建立。
- 疾病活动度采用改良SLEDAI评估,器官损伤采用SLICC损伤指数评估;另以巢式病例对照设计按年龄和病程匹配两国患者。
主要发现
- 苏丹患者女性占95.6%,瑞典患者女性占88.1%(P=0.02)。
- 苏丹患者纳入时年龄更轻(33 vs 47.7岁;P<0.0001),病程更短(5 vs 14年;P<0.0001)。
- 抗Sm抗体在苏丹患者中更常见,而抗dsDNA抗体、抗组蛋白抗体和CICs在瑞典患者中更高。
- 在匹配分析中,瑞典患者SLEDAI有更高趋势;但苏丹患者损伤更多,完全归因于颅/周围神经病变和糖尿病的高频率。
临床怎么用
- 对苏丹SLE患者应关注抗Sm抗体检测及神经病变和糖尿病的筛查与监测。
- 对瑞典SLE患者应关注抗dsDNA抗体、抗组蛋白抗体和CICs的检测。
- 两国患者临床表型差异提示SLE管理需考虑地域和人群背景。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: SLE is known to have an aggressive phenotype in black populations, but data from African cohorts are largely lacking. We therefore compared immunological and clinical profiles between Sudanese and Swedish patients using similar tools. METHODS: Consecutive SLE patients from Sudan (n = 115) and Sweden (n = 340) and from 106 Sudanese and 318 Swedish age- and sex-matched controls were included. All patients fulfilled the 1982 ACR classification criteria for SLE. Ten ANA-associated specificities and C1q-binding immune complexes (CICs) were measured. Cut-offs were established based on Sudanese and Swedish controls, respectively. Disease activity was measured with a modified SLEDAI and organ damage with the SLICC Damage Index. In a nested case-control design, Swedish and Sudanese patients were matched for age and disease duration. RESULTS: Females constituted 95.6% and 88.1% of Sudanese and Swedish patients, respectively (P = 0.02), with younger age at inclusion (33 vs 47.7 years; P < 0.0001) and shorter disease duration (5 vs 14 years; P < 0.0001) among Sudanese patients. Anti-Sm antibodies were more frequent in Sudanese patients, whereas anti-dsDNA, anti-histone and CICs were higher in Swedish patients. In the matched analyses, there was a trend for higher SLEDAI among Swedes. However, Sudanese patients had more damage, solely attributed to high frequencies of cranial/peripheral neuropathy and diabetes. CONCLUSION: While anti-Sm is more common in Sudan than in Sweden, the opposite is found for anti-dsDNA. Sudanese patients had higher damage scores, mainly because of neuropathy and diabetes. Sudanese patients were younger, with a shorter SLE duration, possibly indicating a more severe disease course with impact on survival rates.
引用
- Elbagir S, Elshafie AI, Elagib EM, et al. Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons. Rheumatology (Oxford). 2020. PMID: 31411331. doi:10.1093/rheumatology/kez323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。